Skip to content

Clinical trials

Observational Neurotoxicity Syndromes trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neurotoxicity Syndromes Phase: Observational Country / region: United States Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20052
20061
20072
20081
20092
20101
20115
20151
20211
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Recruiting3
Terminated3
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Children's Oncology Group3
National Cancer Institute (NCI)3
Case Comprehensive Cancer Center2
Alliance for Clinical Trials in Oncology1
Fox Chase Cancer Center1
Gynecologic Oncology Group1
Icahn School of Medicine at Mount Sinai1
Lawrence Einhorn1
M.D. Anderson Cancer Center1
National Institute of Nursing Research (NINR)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neurotoxicity Syndromes23
Brain Neoplasms2
Breast Neoplasms2
Fatigue2
Ovarian Neoplasms2
Pain2
Anxiety Disorders1
Astrocytoma1
Breast Neoplasms, Male1
Carcinoma, Non-Small-Cell Lung1

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.